Home » Picture Gallery » CORRECTION – Medytox Billing Subsidiary Expands Patient Relations Department
Ihren XING-Kontakten zeigen

CORRECTION – Medytox Billing Subsidiary Expands Patient Relations Department

WEST PALM BEACH, FL — (Marketwired) — 12/30/14 — In the news release, “Medytox Billing Subsidiary Expands Patient Relations Department,” issued Wednesday, December 24, 2014 by Medytox Solutions, Inc. (OTCBB: MMMS), we are advised by the company that the fourth paragraph should read “William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories” rather than “William DePond, M.D., COO of Medytox Solutions, Inc., and CEO of Medytox laboratories” as originally issued. Complete corrected text follows.

Medytox Billing Subsidiary Expands Patient Relations Department

Rapid Company Growth Leads to Refined Patient Processing, Relations at Medytox Solutions, Inc. Subsidiary

WEST PALM BEACH, FL — December 24, 2014 — Medical Billing Choices, Inc., a subsidiary of Medytox Solutions, Inc., has created a new Patient Relations department to assist the growing number of patients served through Medytox-owned laboratories with the patient responsibility portion of claims generated for services. Medytox–s network of laboratories provides a full continuum of laboratory and clinical testing services, including sophisticated drug screening, on behalf of physicians and facilities nationwide.

“Our growth has been achieved in part by providing excellent customer service, and the investment in a patient relations department enables us to extend that customer service to patients with a financial liability to our labs after the provision of services ordered by their medical provider,” said Seamus Lagan, CEO of Medytox Solutions, Inc. “Medical Billing Choices– in-house department now serves patients with questions about services provided by a Medytox-owned laboratory. Expanding this department allows us to serve our patients more efficiently by retaining our proactive patient notification process, helping them understand and settle their liability where possible, without causing stress or passing the task to outside collections agencies.”

Medytox–s new department has a special phone line dedicated to addressing patient billing questions. Every patient who visits a Medytox-owned laboratory receives the team–s contact information to discuss their copayments, including payment plans, self-pay, and hardship considerations.

“This new department is part of our commitment to refining and improving our processes as we expand through targeted acquisitions and staffing,” added William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories.

Medytox recently made headlines for its major growth initiatives, such as the receipt of a Clinical Laboratory Permit from the State of New York for its New Jersey-based laboratory, the acquisition of a California-based laboratory, and the launch of its electronic health record (EHR) designed for drug and alcohol treatment through another subsidiary, Medytox Information Technology, Inc.

. Medytox (OTCBB: MMMS) is a holding company that owns and operates businesses in the medical services sector, including clinical laboratory blood and urine testing services. It operates six laboratories throughout the U.S. with a particular emphasis in the provision of drug toxicology and monitoring pain medication utilization. Clients include physicians, clinics and rehabilitation facilities throughout the United States.

Media Contact:
Meieli Sawyer
(305) 668-0070

You must be logged in to post a comment Login


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de Bloggeramt.de blogoscoop